Role of tannic acid against SARS-cov-2 cell entry by targeting the interface region between S-protein-RBD and human ACE2

• Egile Nagusiak: Xi Chen (Egilea), Ziyuan Wang (Egilea), Jing Wang (Egilea), Yifan Yao (Egilea), Qian Wang (Egilea), Jiahao Huang (Egilea), Xianping Xiang (Egilea), Yifan Zhou (Egilea), Yintong Xue (Egilea), Yan Li (Egilea), Xiang Gao (Egilea), Lijun Wang (Egilea), Ming Chu (Egilea), Yuedan Wang (Egilea)
• Formatua: Liburua
• Argitaratua: Frontiers Media S.A., 2022-08-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Coronavirus disease 2019 (COVID-19) was caused by a new coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). SARS-CoV-2 utilizes human angiotensin converting enzyme 2 (hACE2) as the cellular receptor of its spike glycoprotein (SP) to gain entry into cells. Consequently, we focu...